Baird downgraded Vor Bio (VOR) to Neutral from Outperform with a price target of 25c, down from $14, after the company announced plans to wind down its clinical and manufacturing operations, beginning immediately, and pivot to looking for strategic alternatives for the business. The update led Baird to downgrade the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VOR:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue